<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cannabis Investments</title>
	<atom:link href="http://www.cannabisinvestments.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cannabisinvestments.com</link>
	<description>Learn how you can legally invest in cannabis.</description>
	<lastBuildDate>Fri, 03 Feb 2012 14:19:24 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient</title>
		<link>http://www.cannabisinvestments.com/cannabis-science-reports-success-for-4th-brand-new-self-administering-cancer-patient.html</link>
		<comments>http://www.cannabisinvestments.com/cannabis-science-reports-success-for-4th-brand-new-self-administering-cancer-patient.html#comments</comments>
		<pubDate>Fri, 03 Feb 2012 14:19:24 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Brand]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[SelfAdministering]]></category>
		<category><![CDATA[Success]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cannabis-science-reports-success-for-4th-brand-new-self-administering-cancer-patient.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cannabis-science-reports-success-for-4th-brand-new-self-administering-cancer-patient.html';Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient February 2, 2012 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB:CBIS.OB &#8211; News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to introduce a 4th cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cannabis-science-reports-success-for-4th-brand-new-self-administering-cancer-patient.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cannabis Science Issues Corporate &amp; Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal Reports</title>
		<link>http://www.cannabisinvestments.com/cannabis-science-issues-corporate-operations-guidance-to-shareholders-in-regards-to-dividend-market-potential-and-anecdotal-reports.html</link>
		<comments>http://www.cannabisinvestments.com/cannabis-science-issues-corporate-operations-guidance-to-shareholders-in-regards-to-dividend-market-potential-and-anecdotal-reports.html#comments</comments>
		<pubDate>Fri, 03 Feb 2012 00:49:22 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Anecdotal]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Corporate]]></category>
		<category><![CDATA[Dividend]]></category>
		<category><![CDATA[Guidance]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Operations]]></category>
		<category><![CDATA[Potential]]></category>
		<category><![CDATA[Regards]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Shareholders]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cannabis-science-issues-corporate-operations-guidance-to-shareholders-in-regards-to-dividend-market-potential-and-anecdotal-reports.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cannabis-science-issues-corporate-operations-guidance-to-shareholders-in-regards-to-dividend-market-potential-and-anecdotal-reports.html';Cannabis Science Issues Corporate &#038; Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal Reports February 2, 2012 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB:CBIS.ob &#8211; News), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to report an overall corporate and operations guidance outlook as very positive for 2012. Cannabis [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cannabis-science-issues-corporate-operations-guidance-to-shareholders-in-regards-to-dividend-market-potential-and-anecdotal-reports.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side Effects</title>
		<link>http://www.cannabisinvestments.com/fda-fast-tracks-new-cancer-drug-for-skin-cancer-while-cannabis-science-offers-topical-treatment-for-basal-cell-carcinoma-with-no-apparent-side-effects.html</link>
		<comments>http://www.cannabisinvestments.com/fda-fast-tracks-new-cancer-drug-for-skin-cancer-while-cannabis-science-offers-topical-treatment-for-basal-cell-carcinoma-with-no-apparent-side-effects.html#comments</comments>
		<pubDate>Thu, 02 Feb 2012 00:55:58 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Apparent]]></category>
		<category><![CDATA[Basal]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Carcinoma]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Effects]]></category>
		<category><![CDATA[FastTracks]]></category>
		<category><![CDATA[Offers]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Side]]></category>
		<category><![CDATA[Skin]]></category>
		<category><![CDATA[Topical]]></category>
		<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/fda-fast-tracks-new-cancer-drug-for-skin-cancer-while-cannabis-science-offers-topical-treatment-for-basal-cell-carcinoma-with-no-apparent-side-effects.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/fda-fast-tracks-new-cancer-drug-for-skin-cancer-while-cannabis-science-offers-topical-treatment-for-basal-cell-carcinoma-with-no-apparent-side-effects.html';FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side Effects February 1, 2012 Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to inform that news of recent FDA Cancer Drug Approval puts Cannabis [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/fda-fast-tracks-new-cancer-drug-for-skin-cancer-while-cannabis-science-offers-topical-treatment-for-basal-cell-carcinoma-with-no-apparent-side-effects.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are Now Pain Free</title>
		<link>http://www.cannabisinvestments.com/cannabis-science-presents-newest-photographs-from-3rd-cancer-patient-that-show-cancer-tumors-dying-and-areas-that-are-now-pain-free.html</link>
		<comments>http://www.cannabisinvestments.com/cannabis-science-presents-newest-photographs-from-3rd-cancer-patient-that-show-cancer-tumors-dying-and-areas-that-are-now-pain-free.html#comments</comments>
		<pubDate>Tue, 31 Jan 2012 01:13:48 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Areas]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Dying]]></category>
		<category><![CDATA[Free]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Newest]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Photographs]]></category>
		<category><![CDATA[Presents]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Show]]></category>
		<category><![CDATA[Tumors]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cannabis-science-presents-newest-photographs-from-3rd-cancer-patient-that-show-cancer-tumors-dying-and-areas-that-are-now-pain-free.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cannabis-science-presents-newest-photographs-from-3rd-cancer-patient-that-show-cancer-tumors-dying-and-areas-that-are-now-pain-free.html';Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are Now Pain Free January 30, 2012 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cannabis-science-presents-newest-photographs-from-3rd-cancer-patient-that-show-cancer-tumors-dying-and-areas-that-are-now-pain-free.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Naturally Advanced Technologies and Tuscarora Yarns Partner; Plan to Expand Innovative CRAiLAR Flax Fiber Applications</title>
		<link>http://www.cannabisinvestments.com/naturally-advanced-technologies-and-tuscarora-yarns-partner-plan-to-expand-innovative-crailar-flax-fiber-applications.html</link>
		<comments>http://www.cannabisinvestments.com/naturally-advanced-technologies-and-tuscarora-yarns-partner-plan-to-expand-innovative-crailar-flax-fiber-applications.html#comments</comments>
		<pubDate>Mon, 30 Jan 2012 23:15:11 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[NATURALLY ADVAN TECH]]></category>
		<category><![CDATA[Advanced]]></category>
		<category><![CDATA[Applications]]></category>
		<category><![CDATA[Crailar]]></category>
		<category><![CDATA[Expand]]></category>
		<category><![CDATA[fiber]]></category>
		<category><![CDATA[Flax]]></category>
		<category><![CDATA[Innovative]]></category>
		<category><![CDATA[Naturally]]></category>
		<category><![CDATA[Partner]]></category>
		<category><![CDATA[Plan]]></category>
		<category><![CDATA[Technologies]]></category>
		<category><![CDATA[Tuscarora]]></category>
		<category><![CDATA[Yarns]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/naturally-advanced-technologies-and-tuscarora-yarns-partner-plan-to-expand-innovative-crailar-flax-fiber-applications.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/naturally-advanced-technologies-and-tuscarora-yarns-partner-plan-to-expand-innovative-crailar-flax-fiber-applications.html'; VANCOUVER, B.C. and Portland, Ore. (January 30, 2012) &#8211; Naturally Advanced Technologies Inc. (NAT) (OTCBB: NADVF) (TSXV: NAT), which produces and markets one of the first new natural fibers in decades, CRAiLAR, announced it will partner with Tuscarora Yarns, one of the world&#8217;s premier yarn innovators, to explore a host of new blended yarns [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/naturally-advanced-technologies-and-tuscarora-yarns-partner-plan-to-expand-innovative-crailar-flax-fiber-applications.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cancer Patient Success Prompts Cannabis Science To Begin FDA Investigational New Drug (IND) Application Process</title>
		<link>http://www.cannabisinvestments.com/cancer-patient-success-prompts-cannabis-science-to-begin-fda-investigational-new-drug-ind-application-process.html</link>
		<comments>http://www.cannabisinvestments.com/cancer-patient-success-prompts-cannabis-science-to-begin-fda-investigational-new-drug-ind-application-process.html#comments</comments>
		<pubDate>Thu, 26 Jan 2012 01:54:33 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Application]]></category>
		<category><![CDATA[Begin]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Investigational]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Process]]></category>
		<category><![CDATA[Prompts]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Success]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cancer-patient-success-prompts-cannabis-science-to-begin-fda-investigational-new-drug-ind-application-process.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cancer-patient-success-prompts-cannabis-science-to-begin-fda-investigational-new-drug-ind-application-process.html';Cancer Patient Success Prompts Cannabis Science To Begin FDA Investigational New Drug (IND) Application Process January 25, 2012 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to inform that the current progress and success with their numerous self-medicated cancer patients, has lead the Company [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cancer-patient-success-prompts-cannabis-science-to-begin-fda-investigational-new-drug-ind-application-process.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CBIS Updates Latest Remarkable Follow Up Photographs Received from 3rd Cancer Patient</title>
		<link>http://www.cannabisinvestments.com/cbis-updates-latest-remarkable-follow-up-photographs-received-from-3rd-cancer-patient.html</link>
		<comments>http://www.cannabisinvestments.com/cbis-updates-latest-remarkable-follow-up-photographs-received-from-3rd-cancer-patient.html#comments</comments>
		<pubDate>Wed, 25 Jan 2012 02:04:28 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CBIS]]></category>
		<category><![CDATA[Follow]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Latest]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Photographs]]></category>
		<category><![CDATA[Received]]></category>
		<category><![CDATA[Remarkable]]></category>
		<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cbis-updates-latest-remarkable-follow-up-photographs-received-from-3rd-cancer-patient.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cbis-updates-latest-remarkable-follow-up-photographs-received-from-3rd-cancer-patient.html';Cannabis Science Updates Latest Remarkable Follow Up Photographs Received from 3rd Cancer Patient January 24, 2012 Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce new remarkable photographic updates of the 3rd cancer patient, with treatment-resistant squamous cell carcinoma on his head. Cannabis Science has [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cbis-updates-latest-remarkable-follow-up-photographs-received-from-3rd-cancer-patient.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CBIS Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents Cannabis Extracts Killing Cancerous Tumor</title>
		<link>http://www.cannabisinvestments.com/cbis-updates-second-medical-cannabis-cancer-patient-suffering-from-squamous-cell-carcinoma-photo-documents-cannabis-extracts-killing-cancerous-tumor.html</link>
		<comments>http://www.cannabisinvestments.com/cbis-updates-second-medical-cannabis-cancer-patient-suffering-from-squamous-cell-carcinoma-photo-documents-cannabis-extracts-killing-cancerous-tumor.html#comments</comments>
		<pubDate>Fri, 20 Jan 2012 02:45:51 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancerous]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Carcinoma]]></category>
		<category><![CDATA[CBIS]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[Extracts]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Killing]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Photodocuments]]></category>
		<category><![CDATA[Second]]></category>
		<category><![CDATA[Squamous]]></category>
		<category><![CDATA[Suffering]]></category>
		<category><![CDATA[Tumor]]></category>
		<category><![CDATA[Updates]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cbis-updates-second-medical-cannabis-cancer-patient-suffering-from-squamous-cell-carcinoma-photo-documents-cannabis-extracts-killing-cancerous-tumor.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cbis-updates-second-medical-cannabis-cancer-patient-suffering-from-squamous-cell-carcinoma-photo-documents-cannabis-extracts-killing-cancerous-tumor.html';Cannabis Science Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents Cannabis Extracts Killing Cancerous Tumor January 19, 2012 DENVER&#8211;(BUSINESS WIRE)&#8211;Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce that the second patient suffering from basal cell carcinoma (skin cancer) has [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cbis-updates-second-medical-cannabis-cancer-patient-suffering-from-squamous-cell-carcinoma-photo-documents-cannabis-extracts-killing-cancerous-tumor.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells</title>
		<link>http://www.cannabisinvestments.com/second-self-medicated-medical-cannabis-cancer-patient-reports-cannabis-science-brand-extracts-killing-cancer-cells.html</link>
		<comments>http://www.cannabisinvestments.com/second-self-medicated-medical-cannabis-cancer-patient-reports-cannabis-science-brand-extracts-killing-cancer-cells.html#comments</comments>
		<pubDate>Thu, 19 Jan 2012 02:52:27 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Brand]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[Cells]]></category>
		<category><![CDATA[Extracts]]></category>
		<category><![CDATA[Killing]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicated]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Second]]></category>
		<category><![CDATA[Self]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/second-self-medicated-medical-cannabis-cancer-patient-reports-cannabis-science-brand-extracts-killing-cancer-cells.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/second-self-medicated-medical-cannabis-cancer-patient-reports-cannabis-science-brand-extracts-killing-cancer-cells.html';Second Self Medicated Medical Cannabis Cancer Patient Reports Cannabis Science Brand Extracts Killing Cancer Cells December 12, 2011 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB:CBIS.OB &#8211; News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce a second patient suffering skin cancer is self-administering cannabis extracts in collaboration with Cannabis [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/second-self-medicated-medical-cannabis-cancer-patient-reports-cannabis-science-brand-extracts-killing-cancer-cells.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cannabis Science Issues First Market and Revenue Guidance in Regards to the Top 10 Cancer Formulations the Company Intends Focus on over Next Ten Years</title>
		<link>http://www.cannabisinvestments.com/cannabis-science-issues-first-market-and-revenue-guidance-in-regards-to-the-top-10-cancer-formulations-the-company-intends-focus-on-over-next-ten-years.html</link>
		<comments>http://www.cannabisinvestments.com/cannabis-science-issues-first-market-and-revenue-guidance-in-regards-to-the-top-10-cancer-formulations-the-company-intends-focus-on-over-next-ten-years.html#comments</comments>
		<pubDate>Wed, 18 Jan 2012 12:12:56 +0000</pubDate>
		<dc:creator>Joe Smith</dc:creator>
				<category><![CDATA[Cannabis Science, Inc.]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cannabis]]></category>
		<category><![CDATA[company]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Focus]]></category>
		<category><![CDATA[Formulations]]></category>
		<category><![CDATA[Guidance]]></category>
		<category><![CDATA[Intends]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Next]]></category>
		<category><![CDATA[over]]></category>
		<category><![CDATA[Regards]]></category>
		<category><![CDATA[Revenue]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Years]]></category>

		<guid isPermaLink="false">http://www.cannabisinvestments.com/cannabis-science-issues-first-market-and-revenue-guidance-in-regards-to-the-top-10-cancer-formulations-the-company-intends-focus-on-over-next-ten-years.html</guid>
		<description><![CDATA[url='http://www.cannabisinvestments.com/cannabis-science-issues-first-market-and-revenue-guidance-in-regards-to-the-top-10-cancer-formulations-the-company-intends-focus-on-over-next-ten-years.html';Cannabis Science Issues First Market and Revenue Guidance in Regards to the Top 10 Cancer Formulations the Company Intends Focus on over Next Ten Years December 14, 2011 DENVER&#8211;(BUSINESS WIRE)&#8211; Cannabis Science, Inc. (OTCBB: CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that we have a variety of cannabis-based [...]]]></description>
		<wfw:commentRss>http://www.cannabisinvestments.com/cannabis-science-issues-first-market-and-revenue-guidance-in-regards-to-the-top-10-cancer-formulations-the-company-intends-focus-on-over-next-ten-years.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

